← FDA DRUG APPROVALS

FDA ANDA · ANDA076943

TORSEMIDE

Sponsor: HIKMA

APPLICATION
ANDA076943
TYPE
ANDA
ORIGINAL APPROVAL
2005-03-01
LATEST ACTION
2023-07-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued, Prescription

Products

TORSEMIDEDiscontinued
TORSEMIDE 10MG · TABLET · ORAL
TORSEMIDEPrescription
TORSEMIDE 20MG · TABLET · ORAL
TORSEMIDEDiscontinued
TORSEMIDE 5MG · TABLET · ORAL

Approval history

2023-07-21Labeling · Supplement 4 · standardAP
2012-09-26Labeling · Supplement 3 · standardAP
2005-03-01OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →